Dimension Therapeutics' Project Finance Round

Dimension Therapeutics raised a round of funding on June 23, 2014. Investors include Bayer.

Dimension Therapeutics is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-…

Articles about Dimension Therapeutics' Project Finance Round: